Viewpoint

Do All Actinic Keratoses Need Treatment?—Active Surveillance as an Option

JAMA Internal Medicine 10.1001/jamainternmed.2025.7281

January 26, 2026 at 11:00 AM EST

Read the full article

This Viewpoint recommends that patients with actinic keratoses receive active surveillance in primary care rather than routine treatment.

Corresponding Author: Allison C. Billi, MD, PhD, Department of Dermatology, University of Michigan Medical School, NCRC, 2800 Plymouth Rd, Bldg 20, Office 1827, Ann Arbor, MI 48109-2800 (acbilli@umich.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks